Home
Storia in 1 fonti
Gilead Sciences acquires Tubulis for $5bn
Gilead Sciences has concluded its acquisition of Germany-based biotechnology company Tubulis in a transaction valued at up to $5bn.
Raccontata da
pharmaceutical-technology.com
Gilead Sciences has concluded its acquisition of Germany-based biotechnology company Tubulis in a transaction valued at up to $5bn.
